Cytosorbents Corporation (CTSO)
NASDAQ: CTSO · IEX Real-Time Price · USD
0.801
+0.011 (1.39%)
At close: Apr 18, 2024, 4:00 PM
0.790
-0.011 (-1.36%)
After-hours: Apr 18, 2024, 4:05 PM EDT
Cytosorbents Market Cap
Cytosorbents has a market cap or net worth of $41.82 million as of April 18, 2024. Its market cap has decreased by -71.16% in one year.
Market Cap
41.82M
Enterprise Value
44.15M
1-Year Change
-71.16%
Ranking
Category
Stock Price
$0.80
Market Cap Chart
Since December 31, 2007, Cytosorbents's market cap has increased from $5.50M to $41.82M, an increase of 660.39%. That is a compound annual growth rate of 13.25%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Apr 18, 2024 | 43.50M | 1.40% |
Apr 17, 2024 | 42.90M | -0.92% |
Apr 16, 2024 | 43.30M | -8.07% |
Apr 15, 2024 | 47.10M | -0.42% |
Apr 12, 2024 | 47.30M | -3.67% |
Apr 11, 2024 | 49.10M | -5.76% |
Apr 10, 2024 | 52.10M | -2.07% |
Apr 9, 2024 | 53.20M | 1.92% |
Apr 8, 2024 | 52.20M | -4.74% |
Apr 5, 2024 | 54.80M | 5.59% |
Apr 4, 2024 | 51.90M | 3.39% |
Apr 3, 2024 | 50.20M | -3.28% |
Apr 2, 2024 | 51.90M | 5.06% |
Apr 1, 2024 | 49.40M | -4.26% |
Mar 28, 2024 | 51.60M | 2.18% |
Mar 27, 2024 | 50.50M | 4.55% |
Mar 26, 2024 | 48.30M | -1.83% |
Mar 25, 2024 | 49.20M | 1.86% |
Mar 22, 2024 | 48.30M | 3.43% |
Mar 21, 2024 | 46.70M | -1.06% |
Mar 20, 2024 | 47.20M | -2.28% |
Mar 19, 2024 | 48.30M | -7.82% |
Mar 18, 2024 | 52.40M | 9.62% |
Mar 15, 2024 | 47.80M | 10.90% |
Mar 14, 2024 | 43.10M | -4.01% |
View and export this data all the way back to 2007.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Rockwell Medical | 43.42M |
Carmell Therapeutics | 43.21M |
Clene | 42.37M |
ReWalk Robotics | 42.32M |
iCAD, Inc. | 42.20M |
EUDA Health Holdings | 41.62M |
Ocuphire Pharma | 41.44M |
SAB Biotherapeutics | 41.15M |